1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc.

ODTC
Odonate Therapeutics, Inc.US flagOther OTC
22,005.00
USD
+5,005.00
- -
8.05BMarket Cap

Income Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
3
33
91
115
127
68
4
1
+ Selling, General & Admin
- -
- -
5
11
11
10
21
4
1
+ Research & Development
- -
3
28
80
104
117
48
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-3
-33
-91
-115
-127
-68
-4
-1
- Non-Operating (Income) Loss
- -
- -
- -
-2
-3
-1
- -
-14
-10
+ Interest Expense, Net
- -
- -
- -
-2
-3
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
2
3
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-1
- -
-14
-10
Pretax Income
- -
-3
-33
-89
-112
-126
-68
10
9
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
-33
2
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-3
-33
-89
-112
-126
-68
43
7
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-3
-33
-89
-112
-126
-68
43
7
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-3
-33
-89
-112
-126
-68
43
7
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-3
-33
-89
-112
-126
-68
43
7
EBIT
- -
-3
-33
-91
-115
-127
-68
-4
-1
EBITDA
- -
-3
-33
-90
-115
-127
-68
-4
-1
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-3
-33
-91
-115
-127
-68
-4
-1
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
2,354.17
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-470.24
-9,181.55
-97,452.38
-266,347.31
-279,562.5
-262,136.93
-142,027.03
- -
- -
Basic EPS from Cont Ops
-470.24
-9,181.55
-97,452.38
-266,347.31
-279,562.5
-262,136.93
-142,027.03
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
-470.24
-9,181.55
-97,452.38
-266,347.31
-279,562.5
-262,136.93
-142,027.03
- -
- -
Diluted EPS from Cont Ops
-470.24
-9,181.55
-97,452.38
-266,347.31
-279,562.5
-262,136.93
-142,027.03
- -
- -

Balance Sheet (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
Total Current Assets
- -
3
203
140
184
160
75
48
57
+ Cash, Cash Equivalents & STI
- -
3
198
139
180
157
69
48
57
+ Cash & Cash Equivalents
- -
3
198
139
180
157
69
11
40
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
37
17
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
5
1
3
3
6
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
3
5
8
4
55
53
+ Property, Plant & Equip, Net
- -
- -
- -
2
3
6
3
1
- -
+ Property, Plant & Equip
- -
- -
- -
2
4
7
3
1
- -
- Accumulated Depreciation
- -
- -
- -
- -
1
1
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
21
21
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
21
21
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
1
2
2
1
34
32
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
1
2
2
1
34
32
Total Assets
- -
3
203
143
189
168
79
104
110
+ Payables & Accruals
- -
1
7
17
22
24
15
- -
- -
+ Accounts Payable
- -
1
4
11
16
14
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
3
6
7
10
15
- -
- -
+ ST Debt
- -
- -
- -
- -
- -
1
1
- -
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
1
1
- -
1
+ Other ST Liabilities
- -
- -
- -
2
2
3
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
2
2
3
- -
- -
- -
Total Current Liabilities
- -
1
8
18
25
27
16
1
1
+ LT Debt
- -
- -
- -
- -
2
5
4
2
2
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
2
5
4
2
2
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
2
5
4
2
2
Total Liabilities
- -
1
8
19
27
32
20
3
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
9
235
252
402
503
494
493
492
+ Common Stock
4
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
9
235
252
402
502
494
492
492
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-3
-7
-39
-128
-240
-366
-435
-392
-384
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
2
196
124
162
136
59
101
108
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
2
196
124
162
136
59
101
108
Total Liabilities & Equity
- -
3
203
143
189
168
79
104
110
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
2
5
5
3
2
Net Debt
- -
-3
-198
-139
-180
-157
-69
-11
-40
Net Debt to Equity
-124.32
-113.84
-101.08
-112.13
-111.19
-115.51
-116.25
-10.63
-36.57
Tangible Common Equity Ratio
79.29
79.24
96.31
86.91
85.95
81.09
75.02
97.22
97.89
Current Ratio
4.83
4.79
27.02
7.68
7.42
5.91
4.75
82.66
111.72
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
+ Net Income
- -
-3
-33
-89
-112
-126
-68
43
7
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
5
7
12
10
7
-32
2
+ Stock-Based Compensation
- -
- -
3
7
11
10
4
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
-33
2
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
2
1
- -
+ Other Non-Cash Adj
- -
1
2
- -
1
1
1
- -
- -
+ Chg in Non-Cash Work Cap
- -
- -
2
15
3
2
-15
-9
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-5
4
-3
1
-3
6
- -
+ Inc (Dec) in Accts Payable
- -
1
7
11
6
2
-11
-15
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
-1
- -
-1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-2
-26
-67
-97
-113
-76
2
9
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-2
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-2
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
5
221
10
135
87
-14
-2
- -
+ Increase in Capital Stock
- -
5
221
10
135
87
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
-14
-2
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
-58
20
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
37
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
-58
-17
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-2
- -
- -
- -
-58
20
+ Dividends Paid
- -
-1
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
4
3
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
4
221
10
139
90
-13
-2
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
2
196
-59
42
-23
-89
-58
29
EBITDA
- -
-3
-33
-90
-115
-127
-68
-4
-1
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-2
-26
-69
-97
-114
-76
2
9
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
9
Free Cash Flow to Equity
- -
-2
-26
-69
-97
-114
-76
2
9
Free Cash Flow per Basic Share
-491.07
-5,157.74
-77,205.36
-206,589.82
-242,010
-235,605.81
-157,486.49
- -
- -
Price/Free Cash Flow
- -
- -
-26.07
-5.77
-10.76
-6.57
-0.69
- -
- -
Cash Flow to Net Income
1.04
0.56
0.79
0.75
0.86
0.9
1.11
0.04
1.19
Capital Expenditures
- -
- -
- -
-2
- -
- -
- -
- -
- -